» Articles » PMID: 39769346

The Effects of Gender on Mesenchymal Stromal Cell (MSC) Proliferation and Differentiation In Vitro: A Systematic Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2025 Jan 8
PMID 39769346
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stromal cells (MSCs) have the potential for novel treatments of several musculoskeletal conditions due to their ability to differentiate into several cell lineages including chondrocytes, adipocytes and osteocytes. Researchers are exploring whether this could be utilized for novel therapies for joint afflictions. The role of gender in the ability of MSCs to differentiate and proliferate into different cells has not been clearly defined. This systematic review aims to report the current literature on studies, characterized by high quality and in-depth analysis even though quantitatively limited, that have looked at the role of gender in the differentiation and proliferation of MSCs. Sixteen studies were identified during the literature search, reporting 533 patients, of which 202 were male and 331 were female. MSC proliferation, phenotypic analysis and differentiation are reported and contrasted in terms of donor gender. Heterogeneity in methodologies across studies likely contributes to the inconclusive findings presented here, with no discernible statistical disparity observed between genders in differentiation traits. Nevertheless, the proliferation results indicate a notable gender-related impact. Future investigations should aim to ascertain the potential influence of gender on MSC proliferation capacities more conclusively, emphasizing the necessity of standardized protocols for MSC analyses to enhance accuracy and comparability across studies.

Citing Articles

Cell culture expansion media choice affects secretory, protective and immuno-modulatory features of adipose mesenchymal stromal cell-derived secretomes for orthopaedic applications.

Ragni E, Papait A, Taiana M, De Luca P, Grieco G, Vertua E Regen Ther. 2025; 28:481-497.

PMID: 39980717 PMC: 11840939. DOI: 10.1016/j.reth.2025.01.016.

References
1.
Garcia-Alvarez F, Alegre-Aguaron E, Desportes P, Royo-Canas M, Castiella T, Larrad L . Chondrogenic differentiation in femoral bone marrow-derived mesenchymal cells (MSC) from elderly patients suffering osteoarthritis or femoral fracture. Arch Gerontol Geriatr. 2010; 52(2):239-42. DOI: 10.1016/j.archger.2010.03.026. View

2.
Lee H, Min S, Park J . Effects of demographic factors on adipogenic and chondrogenic differentiation in bone marrow-derived stem cells. Exp Ther Med. 2019; 17(5):3548-3554. PMC: 6447802. DOI: 10.3892/etm.2019.7369. View

3.
Zhu C, Wu W, Qu X . Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res. 2021; 13(2):448-461. PMC: 7868850. View

4.
Reumann M, Linnemann C, Aspera-Werz R, Arnold S, Held M, Seeliger C . Donor Site Location Is Critical for Proliferation, Stem Cell Capacity, and Osteogenic Differentiation of Adipose Mesenchymal Stem/Stromal Cells: Implications for Bone Tissue Engineering. Int J Mol Sci. 2018; 19(7). PMC: 6073876. DOI: 10.3390/ijms19071868. View

5.
Barreto-Duran E, Mejia-Cruz C, Leal-Garcia E, Perez-Nunez R, Rodriguez-Pardo V . Impact of donor characteristics on the quality of bone marrow as a source of mesenchymal stromal cells. Am J Stem Cells. 2019; 7(5):114-120. PMC: 6334204. View